BIOMAT Database Logo BIOMAT Database Logo

New orally active cephalosporin esters. 1990

H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Research & Development Division, Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.

UI MeSH Term Description Entries
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D015281 Cefmenoxime A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. Abbott-50192,Cefmax,Cefmenoxime Hydrochloride,Cefmenoxime Hydrochloride (2:1),SCE-1365,Abbott 50192,Abbott50192,Hydrochloride, Cefmenoxime,SCE 1365,SCE1365
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Studies on orally active cephalosporin esters.
March 1987, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
CGP 9000: a new orally active, broad-spectrum cephalosporin.
June 1976, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Studies on orally active cephalosporin esters. II. Chemical stability of pivaloyloxymethyl esters in phosphate buffer solution.
September 1989, Chemical & pharmaceutical bulletin,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Studies on orally active cephalosporin esters. V. A prodrug approach for oral delivery of 3-thiazoliomethyl cephalosporin.
July 1990, Chemical & pharmaceutical bulletin,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Orally active cephaloglycin esters.
November 1971, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Mechanism of action of the new orally active cephalosporin FK027.
July 1984, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.
December 1988, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
Synthesis and oral activity of ME1207, a new orally active cephalosporin.
August 1990, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
In vivo antibacterial activity of FK041, a new orally active cephalosporin.
July 1999, The Journal of antibiotics,
H Yamada, and S Ueda, and M Mutoh, and H Nagata, and H Nouda, and M Fukasawa, and T Okuda
In vitro antibacterial activity of FK041, a new orally active cephalosporin.
July 1999, The Journal of antibiotics,
Copied contents to your clipboard!